Inspira Technologies OXY B.H.N. (NASDAQ:QTEX – Get Free Report) was upgraded by stock analysts at Wall Street Zen to a “hold” rating in a report issued on Saturday.
Separately, Weiss Ratings started coverage on shares of Inspira Technologies OXY B.H.N. in a research note on Wednesday, May 27th. They set a “sell (e+)” rating on the stock. One analyst has rated the stock with a Sell rating, According to MarketBeat.com, the company has a consensus rating of “Sell”.
Get Our Latest Research Report on Inspira Technologies OXY B.H.N.
Inspira Technologies OXY B.H.N. Stock Performance
About Inspira Technologies OXY B.H.N.
Inspira Technologies Oxy B.H.N. Ltd., a specialty medical device company, engages in the research, development, manufacture, and marketing of respiratory support technology to provide an alternative to invasive mechanical ventilation (MV) for the treatment of respiratory failure. Its lead product is the augmented respiration technology system (ART), a respiratory support system comprising minimally invasive, portable dual lumen cannula, which is inserted into the jugular vein and utilizes extra-corporeal direct blood oxygenation to elevate and stabilize declining oxygen saturation levels.
Recommended Stories
- Five stocks we like better than Inspira Technologies OXY B.H.N.
- Aehr Spikes on New Order, But Has Stock Gotten Ahead of Itself?
- Rackspace’s AI Land Grab: Plugging Into the Next Compute Boom
- Satellogic Is Tiny But Its Revenue Growth Is Hard to Ignore
- Why Kroger’s Pullback Could Be a Gift for Patient Investors
Receive News & Ratings for Inspira Technologies OXY B.H.N. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Inspira Technologies OXY B.H.N. and related companies with MarketBeat.com's FREE daily email newsletter.
